Declaration of Voting Results & Voting Rights Announcements • Oct 31, 2022
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
As previously announced, Biotage AB (publ) ("Biotage") has during October 2022 issued 243,252 new class C shares in accordance with the incentive program LTIP 2022 which was adopted by the Annual General Meeting held on April 28, 2022.
Prior to the issue, the total number of shares and votes in Biotage amounted to 66,470,340. Through the issue the number of shares in Biotage has increased by 243,252 shares, corresponding to 24,325.2 votes. As of today, the total number of registered shares of Biotage amount to 66,713,592, whereof 65,983,775 are ordinary shares and 729,817 are class C shares. As of today, the number of votes in Biotage amount to 66,056,756.7, and the registered share capital amounts to SEK 92,731,892.88.
Tomas Blomquist, President and CEO Tel: 0705 23 01 63, [email protected]
Maja Nilsson, CFO Tel: 0733 25 51 70, [email protected]
This information is information that Biotage is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2022-10-31 17:30 CET.
Biotage is a Global Impact Tech Company committed to solving society's problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage's share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm. Website: www.biotage.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.